Skip to main content

TRATAMIENTO NO CONVENCIONAL DE DEGRADACION POR HONGOS DE FARMACOS EN EFLUENTES: DESARROLLO DE PROCESO, MONITORIZACION Y EVALUACION DEL RIESGO

BES-2011-046090

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Formación de Recursos Humanos de Investigación
Subprogram subprograma de Formación de Personal Investigador (FPI)
Call Contratos Predoctorales
Call year 2011
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Formación e Incorporación de Investigadores
Beneficiary centre UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A comparison between biostimulation and bioaugmentation in a solid treatment of anaerobic sludge, drug contentent and microbial evaluation

  • Llorens Blanch, Guillem|||0000-0002-0302-9517
  • Parladé, Eloi|||0000-0001-5750-550X
  • Martínez Alonso, Maira|||0000-0002-3321-2558
  • Gaju, Núria|||0000-0002-4951-2096
  • Caminal i Saperas, Glòria|||0000-0001-9646-6099
  • Blánquez, Paqui|||0000-0003-2443-9977
Emerging pollutants can reach the environment through the sludge of Wastewater Treatment Plants. In this work, the use of Trametes versicolor in biopiles at lab-scale was studied, evaluating its capacity to remove the most hydrophobic Pharmaceuticals and assessing the evolution of the biopiles microbial communities. The total removal of drugs at real concentrations from sewage sludge was assessed for non-inoculated and fungal inoculated biopiles, testing if the re-inoculation of the biopiles after 22 days of treatment would improve the removal yields. It was found that 2 out of the 15 initially detected pharmaceuticals were totally degraded after 22 days, and re-inoculated fungal biopiles achieved higher removal rates than non-re-inoculated fungal biopiles for single compounds and for all the drugs simultaneously: 66.45% and 49.18% re-inoculated and non-re-inoculated biopiles, respectively. Finally, the study of the bacterial and fungal communities revealed that fungal inoculated and non-inoculated biopiles evolved to similar communities adapted to the presence of those drugs.